Keyphrases
Adenovirus Type 5
25%
Adenovirus Vaccine
100%
CD8+ T Cell Epitopes
25%
CD8+ T Cell Response
25%
CD8+ T Cells
100%
Controlled Infection
25%
Future Vaccines
25%
Herpesvirus
25%
Heterologous Prime-boost
25%
ID50
25%
Immune Response
25%
Infected Cells
25%
Intramuscularly
25%
Intranasal
25%
Invariant Chain
25%
Latency
25%
Latent Infection
75%
Long-term Protection
25%
Murine gammaherpesvirus 68 (MHV-68)
100%
Patrolling
25%
Proof of Concept Study
25%
Protective Efficacy
25%
Replication-deficient
25%
Revaccination
25%
T Cells
25%
Vaccine Strategy
25%
Vector Encoding
25%
Viral Entry
25%
Viral Infection
25%
Immunology and Microbiology
Adenoviridae
100%
Arm
16%
Cytotoxic T-Cell
100%
Epitope
16%
Gammaherpesvirus
100%
Herpesviridae
50%
Human immunodeficiency virus
16%
Immune Response
16%
Infectious Agent
16%
Invariant Chain
16%
Serotype
16%
T Cell
16%
Viral Disease
16%
Viral Entry
16%